Tianjin (1)

Advanced HER2 Negative Breast Carcinoma (1)

HRD+Breast Cancer (1)

Recruiting (1)

phase 2 (1)

Tianjin Medical University Cancer Institute and Hospital (1)

fluzoparib+camrelizumab (1)

fluzoparib+chidamide (1)

drug (1)

Other (1)

Interventional (1)

advanced her2 negative breast carcinoma

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Recruiting

Tianjin, Tianjin, China

Tianjin Medical University Cancer Institute and Hospital

Sep 27, 2022